Patients with malabsorption symptoms occurring after certain drug exposures, especially olmesartan or other angiotensin‐II receptor blockers, angiotensin‐converting enzyme inhibitors, mycophenolate, and immune check‐point inhibitors should be investigated for sprue‐like enteropathy. The gene discussed is ACE; the disease is Abnormal intestine morphology.